Skip to main content

Month: May 2022

Alkaline Fuel Announces Appointment of Chief Executive Officer to Drive Global Growth in Energy Transformation

VANCOUVER, British Columbia, May 05, 2022 (GLOBE NEWSWIRE) — Alkaline Fuel Cell Power Corp. (NEO: PWWR) (Frankfurt: 77R, WKN: A3CTYF) (“AFCP” or the “Company”), a company engaged in the development and production of alkaline fuel cell heat and power systems for residential, industrial and commercial markets worldwide, is pleased to announce that Mr. Frank Carnevale has been appointed to position of Chief Executive Officer, to take office on May 10th, 2022. Building on the hydrogen fuel cell power technology and recently acquired pipeline of cogeneration assets, Mr. Carnevale will focus on developing and executing the strategic roadmap to acquire/develop additional net zero emission energy assets, strategic growth opportunities and investor awareness. “AFCP is on the front lines of developing the net zero...

Continue reading

Industrial Nanotech Welcomes Back Pemex

BROOMFIELD, Colo., May 05, 2022 (GLOBE NEWSWIRE) — via InvestorWire – Industrial Nanotech Inc, (OTC Pink Sheets: INTK), a global nanoscience solutions and product development leader, announces today that the Company received a request for a specification for a tank project from an existing customer, Pemex. The total number of gallons is 3,600 and the retail price for that product volume is $622,800 before standard volume discounts. The requested documents were submitted yesterday. Stuart Burchill, CEO/CTO of Industrial Nanotech Inc., explains: “Pemex has used our products successfully before so we expect the relationship to be successful yet again. One of the prior Pemex projects used our High Heat product on large valves on one of their offshore drilling platforms and is featured in our Oil & Gas product literature.” View...

Continue reading

SKEL fjárfestingafélag hf.: ISK 3,342 million profit after tax in Q1 2022

SKEL fjárfestingafélag hf.: ISK 3,342 million profit after tax in Q1 2022. Attached is an announcement relating to the financial accounts and investor presentation of SKEL for the first quarter of 2022. A presentation of the Company’s financial accounts will be held on 6 May at 08:30 at Borgartún 26, 8th floor, where Jón Ásgeir Jóhannesson, Chairman of Board, will present the accounts and Company operations. For further information, please contact Jón Ásgeir Jóhannesson, fjarfestar@skel.is. www.skel.is https://www.linkedin.com/company/skel-hf/AttachmentsSKEL Announcement Q1 2022SKEL Summary Q1 2022SKEL Investor presentation Q1 2022

Continue reading

Tarkett – Information on the total number of voting rights and shares in Tarkett’s share capital as of April 30, 2022

PARIS, FRANCE, May 5, 2022 – Information on the total number of voting rights and shares in Tarkett’s share capital as of April 30, 2022 (Article L233-8-II of the French Commercial Code andArticle 223-16 of the General Regulation of the Autorité des marchés financiers)Date Total number of shares in the share capital Total number of voting rightsAs of April 30, 2022   65,550,281   Number of theoretical voting rights: 65,802,231Number of exercisable voting rights: 65,554,676** After deduction of the treasury shares without voting rights. *** Investor Relations Contact investors@tarkett.com Media contacts Tarkett – communication@tarkett.com Brunswick – tarkett@brunswickgroup.com – Tel.: +33 (0) 1 53 96 83 83 About Tarkett With a history of 140 years, Tarkett is a worldwide leader in innovative flooring...

Continue reading

UPDATE — Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement

PORTLAND, Maine, May 05, 2022 (GLOBE NEWSWIRE) — Certain immaterial corrections have been made to the second and fifth paragraphs. ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced that Mark Wustenberg, DVM has joined its sales and marketing team as Commercial Leader of Stakeholder Engagement. Dr. Wustenberg has extensive experience serving the dairy industry both at the producer and the processor levels. Most recently, he managed a private consulting practice working with dairy producers and dairy-related agribusinesses. Prior to that, he worked in various executive positions at Tillamook County Creamery Association,...

Continue reading

Publishing of Eimskip’s first quarter 2022 results

Investor meeting on 13 May 2022 Eimskipafélag Íslands hf. will publish its first quarter 2022 results after market closing on Thursday 12 May 2022. Eimskip invites investors and market participants to a meeting where Vilhelm Thorsteinsson, CEO and María Björk Einarsdóttir, CFO, will present the results. The meeting will be held on Friday 13 May at 8:30 GMT at the Company‘s headquarters, Sundabakki 2, second floor. Participants are required to register their attendance before the end of 12 May by clicking here The meeting will also be webcasted live in Icelandic on www.eimskip.com/investors. Investors can send questions before and during the meeting to the email investors@eimskip.com. Documents and a recording of the meeting will be available at the Company’s investor relations website, www.eimskip.is/investors. For further information...

Continue reading

RVL Pharmaceuticals plc to Discuss First Quarter 2022 Financial Results and Provide Commercial Update

Conference call to be held Thursday, May 12, 2022, at 8:30 a.m. ET BRIDGEWATER, N.J., May 05, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced that the Company will release its first quarter 2022 financial results and provide a commercial update on Thursday, May 12, 2022, before U.S. financial markets open. Brian Markison, Chief Executive Officer, James “JD” Schaub, Chief Operating Officer, and Mike DePetris, Interim Chief Financial Officer, will host a conference call as follows:Date   Thursday, May 12, 2022Time   8:30 a.m. ETToll free (U.S.)   866-342-8591International   203-518-9713Conference ID   RVLPQ122Webcast (live and replay)   www.rvlpharma.com under the “Investors & News” sectionAbout RVL Pharmaceuticals...

Continue reading

Freddie Mac Multifamily Impact Bonds Surpass $10 Billion Mark

New Report Shows Success of Green, Social and Sustainability Bonds MCLEAN, Va., May 05, 2022 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) Multifamily released its annual Impact Bonds Report detailing the company’s successful efforts to issue more than $10 billion in Green, Social and Sustainability Bonds since 2019. The Impact Bonds offerings were created to provide investors an opportunity to support multifamily properties that address persistent housing challenges, particularly environmental and social issues. “Freddie Mac doubled our total Impact Bond issuance in 2021 underscoring our efforts to support rental housing that is green, affordable and meets the diverse needs of communities throughout the country,” said Robert Koontz, the head of Capital Markets for Freddie Mac Multifamily. “These innovative offerings enhance our...

Continue reading

Fuzzy Redefining Personalized Pet Care Following Surge in Company Growth

Fuzzy acquires Dandy and expands executive leadership team SAN FRANCISCO, May 05, 2022 (GLOBE NEWSWIRE) — Fuzzy, the leading digital pet health company, today announced the acquisition of Dandy, a first-of-its-kind personalized pet supplement company, and a new Vice President of Strategy & Business Operations to build on surging demand for personalized pet care. The additions come on the heels of unprecedented growth across the company’s telehealth and e-commerce offerings. “Pet care has dramatically changed over the past decade, going from reactive emergency care to a more thoughtful, proactive care approach. At Fuzzy, we know there is no one-size-fits-all care plan and we’re on a mission to provide access to care that meets the needs of all our pet parents,” said Zubin Bhettay, co-founder and CEO of Fuzzy. “Through...

Continue reading

IGE+XAO: Definitive completion of the merger of IGE+XAO into Schneider Electric

  Toulouse, 5 May 2022, IGE+XAO Group announces:     Definitive completion of the merger of IGE+XAO into Schneider Electric     IGE+XAO announces that the annual general meetings of shareholders of IGE+XAO and Schneider Electric SE (compartment A, ISIN code FR0000121972) (“Schneider Electric”), held respectively on May 4 and May 5, 2022, have approved the merger of IGE+XAO into Schneider Electric, on the basis of an exchange ratio of 5 Schneider Electric shares for 3 IGE+XAO shares.   The merger leading to the dissolution without liquidation of IGE+XAO has taken effect today following the annual general meeting of Schneider Electric, it being specified that it has retroactive effect for accounting and tax purposes as from January 1, 2022.   The new Schneider Electric shares resulting from the merger will be admitted to trading on compartment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.